SCHEMBL14236243

SCHEMBL14236243

CC[C@](C)(Nc1nc(-c2c[nH]c3ncncc23)ncc1F)C(=O)NCC(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 5/20 0.56
JAK2 O60674 4/20 0.56
PLK4 O00444 1/20 0.56
ROCK2 O75116 1/20 0.56
STK10 O94804 1/20 0.56
ABL1 P00519 1/20 0.56
PRKCB P05771 1/20 0.56
MET P08581 1/20 0.56
TOP2A P11388 1/20 0.56
PRKCA P17252 1/20 0.56
CSNK2A2 P19784 1/20 0.56
JAK1 P23458 1/20 0.56
MARK3 P27448 1/20 0.56
TYK2 P29597 1/20 0.56
ABL2 P42684 1/20 0.56
CDK9 P50750 1/20 0.56
CDK17 Q00537 1/20 0.56
TOP2B Q02880 1/20 0.56
PRKCD Q05655 1/20 0.56
ROCK1 Q13464 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14236361 1.00 JAK3 (0.56) JAK3JAK2PLK4ROCK2STK10
SCHEMBL14236631 0.92 JAK3 (0.47) JAK3JAK2PLK4ROCK2STK10
SCHEMBL14237810 0.90 JAK3 (0.47) JAK3JAK2PLK4ROCK2STK10
SCHEMBL5635275 0.90 JAK3 (0.47) JAK3JAK2PLK4ROCK2STK10
SCHEMBL2630188 0.88 JAK2 (0.56) JAK3JAK2PLK4ROCK2STK10
SCHEMBL2630386 0.87 JAK3 (0.75) JAK3JAK2PLK4ROCK2STK10
SCHEMBL13199371 0.87 JAK3 (0.75) JAK3JAK2PLK4ROCK2STK10
SCHEMBL14236213 0.87 JAK3 (0.45) JAK3JAK2PLK4ROCK2STK10
SCHEMBL14236251 0.87 JAK3 (0.45) JAK3JAK2PLK4ROCK2STK10
SCHEMBL2630132 0.86 PLK4 (0.55) JAK3JAK2PLK4ROCK2STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580802-B2 Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-11-12 US disclosed
US-8580802-B2 Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-11-12 US disclosed
EP-1931674-B1 DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMA (US) 2012-12-12 EP disclosed
EP-2532667-A1 Deazapurines useful as inhibitors of janus kinases Vertex Pharmaceuticals Incorporated (US) 2012-12-12 EP disclosed
WO-2007041130-A2 DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-04-12 WO disclosed